An Ad Hoc Random Initialization Deep Neural Network Architecture for Discriminating Malignant Breast Cancer Lesions in Mammographic Images
暂无分享,去创建一个
Andrea Duggento | Nicola Toschi | Maria Guerrisi | G. L. Cascella | Davide Cascella | Carlo Cavaliere | Marco Aiello | Giovanni Conte | N. Toschi | A. Duggento | M. Guerrisi | M. Aiello | C. Cavaliere | D. Cascella | Giovanni Conte
[1] T. Helbich,et al. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? , 2007, Radiology.
[2] Danna Zhou,et al. d. , 1840, Microbial pathogenesis.
[3] Olaf Sporns,et al. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology. , 2018, Journal of Alzheimer's disease : JAD.
[4] Pascal Vincent,et al. Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[5] Jürgen Schmidhuber,et al. Deep learning in neural networks: An overview , 2014, Neural Networks.
[6] Rob Fergus,et al. Visualizing and Understanding Convolutional Networks , 2013, ECCV.
[7] Daniel Lévy,et al. Breast Mass Classification from Mammograms using Deep Convolutional Neural Networks , 2016, ArXiv.
[8] William Hang,et al. GlimpseNet : Attentional Methods for Full-Image Mammogram Diagnosis , 2017 .
[9] W. Marsden. I and J , 2012 .
[10] Aaas News,et al. Book Reviews , 1893, Buffalo Medical and Surgical Journal.
[11] Benzhong Wang,et al. Herceptin as a single agent in the treatment of patients with metastatic breast cancer. , 2015, Journal of cancer research and therapeutics.
[12] Yuan Yu,et al. TensorFlow: A system for large-scale machine learning , 2016, OSDI.
[13] Richard H. Moore,et al. Current Status of the Digital Database for Screening Mammography , 1998, Digital Mammography / IWDM.
[14] Brendan J. Frey,et al. Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets , 2016, Proceedings of the IEEE.
[15] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.
[16] M. Wallis,et al. A review of false negative mammography in a symptomatic population. , 1991, Clinical radiology.
[17] Thomas Brox,et al. U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.
[18] Niall O'Higgins,et al. Analysis of patients with false negative mammography and symptomatic breast carcinoma , 2007, Journal of surgical oncology.
[19] Li Shen,et al. End-to-end Training for Whole Image Breast Cancer Diagnosis using An All Convolutional Design , 2017, ArXiv.
[20] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[21] Orazio Schillaci,et al. Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Guang Shi,et al. Molecular markers' progress of breast cancer treatment efficacy. , 2015, Journal of cancer research and therapeutics.
[23] C. D'Orsi,et al. Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.
[24] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[25] Orazio Schillaci,et al. Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork. , 2018, Future oncology.
[26] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[27] Alfonso Frigerio,et al. False-Positive Results in Mammographic Screening for Breast Cancer in Europe: A Literature Review and Survey of Service Screening Programmes , 2012, Journal of medical screening.
[28] R.L.N Godone,et al. Clinical and molecular aspects of breast cancer: Targets and therapies. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[29] J. Geraghty,et al. Reasons underlying negative mammography in patients with palpable breast cancer. , 1994, Clinical radiology.
[30] Miguel Ángel Guevara-López,et al. Representation learning for mammography mass lesion classification with convolutional neural networks , 2016, Comput. Methods Programs Biomed..
[31] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[32] Phoebe E. Freer,et al. False-negative rate of combined mammography and ultrasound for women with palpable breast masses , 2015, Breast Cancer Research and Treatment.
[33] Ausif Mahmood,et al. A Framework for Designing the Architectures of Deep Convolutional Neural Networks , 2017, Entropy.
[34] Tsuyoshi Murata,et al. {m , 1934, ACML.
[35] Yann LeCun,et al. Convolutional networks and applications in vision , 2010, Proceedings of 2010 IEEE International Symposium on Circuits and Systems.
[36] E. Pisano,et al. Consequences of false-positive screening mammograms. , 2014, JAMA internal medicine.
[37] Hiba Chougrad,et al. Deep Convolutional Neural Networks for breast cancer screening , 2018, Comput. Methods Programs Biomed..
[38] Ping Tang,et al. Update on Immunohistochemical Analysis in Breast Lesions. , 2017, Archives of pathology & laboratory medicine.
[39] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[40] H. Nelson,et al. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[41] Jay Parikh,et al. Improved prognosis of women aged 75 and older with mammography-detected breast cancer. , 2014, Radiology.
[42] P. Alam. ‘E’ , 2021, Composites Engineering: An A–Z Guide.
[43] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.